Cargando…
High BM plasma S100A8/A9 is associated with a perturbed microenvironmentand poor prognosis in myelodysplastic syndromes
Autores principales: | Wang, Yu-Hung, Lin, Chien-Chin, Yao, Chi-Yuan, Amaral, Fabio M. R., Yu, Shan-Chi, Kao, Chein-Jun, Shih, Pin-Tsen, Hou, Hsin-An, Chou, Wen-Chien, Tien, Hwei-Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248090/ https://www.ncbi.nlm.nih.gov/pubmed/36705979 http://dx.doi.org/10.1182/bloodadvances.2022008958 |
Ejemplares similares
-
The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndrome
por: Yang, Yi-Tsung, et al.
Publicado: (2018) -
A CIBERSORTx-based immune cell scoring system could independently predict the prognosis of patients with myelodysplastic syndromes
por: Wang, Yu-Hung, et al.
Publicado: (2021) -
Higher RUNX1 expression levels are associated with worse overall and leukaemia‐free survival in myelodysplastic syndrome patients
por: Wang, Yu‐Hung, et al.
Publicado: (2022) -
S171: HIGHER MDMX EXPRESSION WAS ASSOCIATED WITH HYPOMETHYLATING AGENT RESISTANCE AND WORSE SURVIVAL IN MYELODYSPLASTIC SYNDROME PATIENTS, INFERRING IT A POTENTIAL THERAPEUTIC TARGET
por: Wang, Yu-Hung, et al.
Publicado: (2023) -
High expression of dedicator of cytokinesis 1 (DOCK1) confers poor prognosis in acute myeloid leukemia
por: Lee, Sze-Hwei, et al.
Publicado: (2017)